The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ASENSUS SURGICAL, INC. COM NEW 04367G103 944 510,142 SH   OTR 1,2 0 510,142 0
DECIPHERA PHARMACEUTICALS INC COM 24344T101 15,289 449,951 SH   OTR 1,2 0 449,951 0
X4 PHARMACEUTICALS INC COM 98420X103 1,648 311,490 SH   OTR 1,2 0 311,490 0
SUTRO BIOPHARMA INC COM 869367102 34,466 1,824,542 SH   OTR 1,2 0 1,824,542 0
BICYCLE THERAPEUTICS PLC SPONSORED ADS 088786108 59,742 1,436,456 SH   OTR 1,2 0 1,436,456 0
MISONIX, INC. COM 604871103 42,859 1,694,017 SH   OTR 1,2 0 1,694,017 0
ADAPTHEALTH CORP COM 00653Q102 45,209 1,941,118 SH   OTR 1,2 0 1,941,118 0
Repligen Corporation COM 759916109 4,203 14,541 SH   OTR 1,2 0 14,541 0